<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02580838</url>
  </required_header>
  <id_info>
    <org_study_id>B-BR-102-032</org_study_id>
    <nct_id>NCT02580838</nct_id>
  </id_info>
  <brief_title>The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke</brief_title>
  <official_title>The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cheng-Kung University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cheng-Kung University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine whether early use of OnabotulinumtoxinA is more
      effective to improve functional outcomes of upper limb in patients with stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many patients surviving stroke have significant impairment of function in the affected upper
      limb due to the development of spasticity. Botulinum toxin type A injection is a powerful
      treatment option for control of spasticity. In this study, the patients will be randomly
      assigned into three groups: early OnabotulinumtoxinA group will receive OnabotulinumtoxinA
      injection when their spasticity develop, late OnabotulinumtoxinA group will have injection at
      6 months after emergence of spasticity, the third group will not have OnabotulinumtoxinA
      intervention. The aim of this randomized controlled study is to evaluate the effects of early
      and late injection of botulinum toxin type A on upper limb function in patients with stroke.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Ashworth Scale</measure>
    <time_frame>change from baseline Modified Ashworth Scale at 4 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>early OnabotulinumtoxinA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>OnabotulinumtoxinA will be injected immediately when spasticity develop in early OnabotulinumtoxinA group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>late OnabotulinumtoxinA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>OnabotulinumtoxinA will be injected at 6 months after emergence of spasticity in late OnabotulinumtoxinA group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no OnabotulinumtoxinA group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>OnabotulinumtoxinA will not be injected for this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OnabotulinumtoxinA</intervention_name>
    <description>Early OnabotulinumtoxinA group will receive OnabotulinumtoxinA injection when their spasticity develop, late OnabotulinumtoxinA group will have injection at 6 months after emergence of spasticity, the third group will not have OnabotulinumtoxinA intervention.</description>
    <arm_group_label>early OnabotulinumtoxinA group</arm_group_label>
    <arm_group_label>late OnabotulinumtoxinA group</arm_group_label>
    <other_name>Botox</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stroke affecting one body side

          -  spasticity develops after stroke

        Exclusion Criteria:

          -  musculoskeletal conditions that affected upper limb function prior to stroke

          -  concurrent use of anti-spasticity medications

          -  patients with neuromuscular junction or myopathic disorders such as myasthenia gravis
             or others

          -  patients with a known allergy to any onabotulinumtoxinA or to any of the excipients of
             onabotulinumtoxinA (such as human serum albumin)

          -  patients who are pregnant or may become pregnant at the time of the proposed injection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Lin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Lin</last_name>
    <phone>886-6-2353535</phone>
    <phone_ext>2666</phone_ext>
    <email>richelin@mail.ncku.edu.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Richard Lin</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital</name>
      <address>
        <city>Tainan</city>
        <zip>138</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Lin</last_name>
      <phone>Tel: 886-6-2353535</phone>
      <phone_ext>2666</phone_ext>
      <email>richelin@mail.ncku.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2015</study_first_submitted>
  <study_first_submitted_qc>October 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2015</study_first_posted>
  <last_update_submitted>October 18, 2015</last_update_submitted>
  <last_update_submitted_qc>October 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Spasticity</keyword>
  <keyword>OnabotulinumtoxinA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

